In the weeks after the crash, she scored over 100 out of a possible 132, indicating extreme impairment
No, the FDA has not approved any transdermal patch for GLP-1 delivery
The good news is that many users of branded GLP-1s qualify for partial or full insurance coverage, especially if they have diabetes or a BMI over 30
A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo
Retatrutide: The Triple Agonist The newest GLP-1 medication in development, retatrutide , is showing jaw-dropping results in clinical trials
doi:10.1016/S2468-1253(22)00338-7 Thorens B, Porret A, Bhler L, Deng SP, Morel P, Widmann C